165 filings
Page 7 of 9
S-1MEF
ebbfva1j1kvi
12 Nov 20
Registration of additional securities for an S-1
8:35pm
8-K
99p mc9ohng
10 Nov 20
Other Events
5:14pm
8-K
c0kgb7y5 la5
10 Nov 20
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
4:19pm
CORRESP
6if6evc
10 Nov 20
Correspondence with SEC
12:00am
CORRESP
lqxy78nu7b
10 Nov 20
Correspondence with SEC
12:00am
UPLOAD
ksu8gvva
9 Nov 20
Letter from SEC
12:00am
DRS
6s03jxjsw4bxlhkyhnv7
3 Nov 20
Draft registration statement
12:00am
8-K
wqyhnhmffv
28 Oct 20
Termination of a Material Definitive Agreement
8:01am
8-K
368z ghl6
20 Oct 20
Other Events
8:04am
8-K
5n3a09yw
11 Sep 20
Other Events
4:02pm
8-K
c8gnhg2 aguw9
8 Sep 20
Corporate Presentation September 2020
8:04am
8-K
qbwbyy5ih4w8wyhis
13 Aug 20
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
7:29am
8-K
3bdjdb8 nqpigzx
4 Aug 20
Keros Therapeutics, Inc. Announces Completion of Dosing of Planned Cohorts in KER-047 Phase 1 Trial and Provides Program Update
8:32am
8-K
hb7cx
26 Jun 20
Regulation FD Disclosure
7:03am
8-K
0lmrqcevmsc
12 Jun 20
Other Events
7:08am
8-K
c4rninil
2 Jun 20
Corporate Presentation June 2020
4:19pm
10-Q
vdje javxjnxccboefpr
22 May 20
Quarterly report
7:16am